Skip to main content

Log in

Search

(0)

Search

Discover us
Discover opnMe®
Join our vibrant scientific community and delve into our open science portal. Explore exclusive news, research publications, our specialized search tool opnMINER® and FAQs, all dedicated to igniting curiosity and pioneering solutions. Apply for PostDoc research funding on cutting-edge topics. Together, we can drive innovation in areas of high unmet medical need.

Explore now
- About us
- News
- Publications
- opnMINER
- FAQs
Order Molecules
Order molecules
Enhance your research by browsing and ordering molecules for free, including free shipping. Use them as experimental biological or chemical tools. Any subsequent IP belongs to you; we encourage you to publish freely.

Learn more
Collaborate with us
Collaborate with us
We are extending a hand to experts around the world, looking for researchers with innovative approaches to address unmet medical needs. From molecules, to funding, to direct cooperation, to molecular biology questions and technology partnerships; we offer a range of collaborative initiatives and resources aimed at transforming lives for generations.

Discover all
PostDoc Grants
PostDoc grants with opnMe®
Unlock the next step of your research career with fully funded PostDoc grants at Boehringer Ingelheim. Explore all opportunities for high-caliber talent, pitch your scientific approaches for well-defined research questions, and start your work at one of our discovery research sites.

Learn more
- opn2TALENTS

Don't miss an opportunity to progress your research! Get first-look access to open calls to submit novel ideas for our research collaboration opportunities and stay informed of new molecule additions.

Log in

Home
opnMe online seminar
Register for our opnMe online seminar – How sharing an inhibitor targeting the SOS1-RAS axis generated new insights in oncology and diabetes

Register for our opnMe online seminar – How sharing an inhibitor targeting the SOS1-RAS axis generated new insights in oncology and diabetes

September 25, 2025, 8:00 am PST | 11:00 am EST | 4:00 pm GMT | 5:00 pm CET

60 minutes including interactive session

Overview:

Join us and learn how a novel selective molecule shared by opnMe drove scientific discoveries in two distinct disease areas: oncology and diabetes.

Session highlights:

Discover how open science can accelerate SOS1-RAS discovery across disciplines
Gain insights into SOS1-activating mutations in cancer
Explore a novel approach to β-cell regeneration and its implications for treating diabetes
Engage directly with the experts and get inspired for your own research
Get an official opnMe certificate of attendance*

Meet our experts:

Matthew Sale, University of California, San Francisco, United States
Ioannis Serafimidis, Biomedical Research Foundation of the Academy of Athens, Greece
Marco Hofmann, Oncology Research, Boehringer Ingelheim
Ana Puhl, Cardio-Renal-Metabolic Disease Research, Boehringer Ingelheim

*Please note that the name and email address you provide during registration will be used to generate your certificate of attendance.

Sign up to news

Title

First Name

Last Name

Country

Institution

Email

Email

Confirm email

*Required field

Please also sign me up to the opnme.com newsletter

What are you interested in hearing about? Please select one or more topics of interest:

Molecules for free

Molecules for collaboration

opn2EXPERTS

techMATCH

opn2TALENTS

opnMe online seminars

Sustainability

opnMe general / All opnMe topics

CAPTCHA This is for testing whether or not you are a human visitor and to prevent automated spam submissions:

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

I hereby agree to the Privacy Policy and Terms of Use

After successful registration you will receive an email with a unique link to participate in this online seminar.

https://de.linkedin.com/company/opnme
https://www.youtube.com/user/boehringeringelheim/
https://www.facebook.com/boehringeringelheim/

About us
Terms of use
Privacy
Publications
Imprint
Contact us

Copyright ©2025 Boehringer Ingelheim International GmbH. All rights reserved.